Company Filing History:
3 out of 3,223 
1 out of 639 
Years Active: 1989-2011
Title: The Innovative Contributions of Shmuel Cabilly
Introduction: Shmuel Cabilly is a notable inventor based in Monrovia, California, recognized for his significant contributions to the field of immunology. With a total of three patents to his name, Cabilly's innovations have advanced the methods for producing important biomedical products.
Latest Patents: Cabilly's latest patents focus on "Methods of making antibody heavy and light chains having specificity for a desired antigen." This invention relates to processes for producing an immunoglobulin or an immunologically functional fragment that contains at least the variable domains of the immunoglobulin heavy and light chains. Remarkably, these processes utilize one or more vectors that can produce both the heavy and light chains or their fragments within a single cell. Additionally, it encompasses the vectors employed in this production, alongside the transformed cells that carry these vectors.
Another significant patent of his is titled "Methods of producing immunoglobulins, vectors and transformed host cells for use therein," which shares similar themes and processes aimed at enhancing the production of immunoglobulins and their components, thus reinforcing his dedication to advancing healthcare solutions.
Career Highlights: Throughout his career, Shmuel Cabilly has worked with esteemed companies such as Genentech, Inc. and City of Hope. His roles in these organizations have allowed him to innovate and develop groundbreaking techniques that pave the way for new treatments and therapies.
Collaborations: Cabilly's work has also led him to collaborate with notable individuals in the field, including Herbert L. Heyneker and William E. Holmes. These partnerships have likely enabled the rapid development and implementation of his innovations, enhancing their impact on the scientific community.
Conclusion: Shmuel Cabilly's contributions to biotechnology and immunology have facilitated notable advancements in the production of immunoglobulins. His patents reflect a profound understanding of both science and innovation, positioning him as a prominent figure in the field. Through his collaborations and work with prestigious organizations, Cabilly continues to influence the future of healthcare and biomedicine.